Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
The contract will cover maintenance of existing equipment and consumables for existing equipment to perform Cell Selection & Processing procedures. The Cellular & Molecular Therapies (CMT) laboratories within NHS Blood and Transplant ( NHSBT) provide a range of services to support haemopoietic stem cell transplantation including collection, processing, and cryopreservation of stem cells. An important part of the services offered by CMT is the purification of stem cells and depletion of other cells, such as CD3+, TCRαβ, CD19+ cells, that may cause complications in the transplant procedures.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Miltenyi Biotec | 03096272 | £5,200,000 | - |
Government spending data: This supplier has received £855,511 in 169 payments (over £25k) from DEFRA, Guy's and St Thomas' NHS FT, Manchester University NHS Foundation Trust, UKRI, Plymouth Hospitals NHS Trust (2023-01-12 to 2026-03-31). View full payment history →